{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:02:08Z","timestamp":1761742928779},"reference-count":18,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2006,7,20]],"date-time":"2006-07-20T00:00:00Z","timestamp":1153353600000},"content-version":"vor","delay-in-days":8236,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Prostate"],"published-print":{"date-parts":[[1984,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Factors affecting the validity and interpretation of androgen receptor (AR) assays on prostatic carcinoma tissue are discussed, and attempts to relate AR concentration with response of the patient to hormonal manipulation are reviewed. It is concluded that nuclear AR content may be useful in evaluating prognosis and likely response to hormonal therapy, and that, owing to the heterogeneity of many prostatic carcinoma specimens, a reliable histochemical method for the assessment of androgen sensitivity would be a valuable supplement to the biochemical assay.<\/jats:p>","DOI":"10.1002\/pros.2990050503","type":"journal-article","created":{"date-parts":[[2007,2,21]],"date-time":"2007-02-21T00:08:38Z","timestamp":1172016518000},"page":"477-483","source":"Crossref","is-referenced-by-count":14,"title":["Clinical applications and value of receptor levels in treatment of prostate cancer"],"prefix":"10.1002","volume":"5","author":[{"given":"J. G.","family":"Connolly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. G.","family":"Mobbs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,7,20]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-1-4832-2866-2.50015-5"},{"key":"e_1_2_1_3_2","first-page":"193","article-title":"Distribution of radioactivity in different organs of the male rat following administration of testosterone \u22121,2\u2010H3","volume":"3","author":"Tveter KJ","year":"1968","journal-title":"Res Steroids"},{"key":"e_1_2_1_4_2","first-page":"23","volume-title":"Estrogen Target Tissues and Neoplasia","author":"Jensen EV","year":"1972"},{"key":"e_1_2_1_5_2","first-page":"4669","article-title":"Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer","volume":"37","author":"Knight WA","year":"1977","journal-title":"Cancer Res"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/pros.2990030405"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.0740001"},{"key":"e_1_2_1_8_2","first-page":"751","article-title":"Studies on carcinogenesis of human prostate. II. Long\u2010term explant culture of normal prostate and benign prostatic hyperplasia: Light microscopy","volume":"69","author":"Sanefuji H","year":"1982","journal-title":"J Natl Cancer Inst"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/pros.2990030304"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197910)44:4<1173::AID-CNCR2820440402>3.0.CO;2-C"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(81)92829-4"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)53868-9"},{"key":"e_1_2_1_13_2","first-page":"225","volume-title":"Steroid Receptors: Metabolism and Prostatic Cancer","author":"Mobbs BG","year":"1980"},{"key":"e_1_2_1_14_2","first-page":"355","volume-title":"Progesterone and Progestins","author":"Saez S","year":"1983"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-4731(79)90092-X"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19820301)49:5<984::AID-CNCR2820490523>3.0.CO;2-P"},{"key":"e_1_2_1_17_2","first-page":"337","article-title":"Histochemical observation of R1881 binding protein in human benign prostatic hypertrophy","volume":"18","author":"Naito H","year":"1981","journal-title":"Invest Urol"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/pros.2990020408"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)54440-7"}],"container-title":["The Prostate"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpros.2990050503","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pros.2990050503","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T12:22:50Z","timestamp":1697804570000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pros.2990050503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1984,1]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1984,1]]}},"alternative-id":["10.1002\/pros.2990050503"],"URL":"https:\/\/doi.org\/10.1002\/pros.2990050503","archive":["Portico"],"relation":{},"ISSN":["0270-4137","1097-0045"],"issn-type":[{"value":"0270-4137","type":"print"},{"value":"1097-0045","type":"electronic"}],"subject":[],"published":{"date-parts":[[1984,1]]}}}